These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2903400)

  • 21. [Rehabilitation in haemophilic children with inhibitors using recombinant activated factor VII].
    Janić D; Petronić I; Dokmanović L; Krstovski N; Lazić J; Rodić P
    Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():226-30. PubMed ID: 19562874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effective and safe use of recombinant factor VIIa (NovoSeven) in elderly mild haemophilia A patients with high-titre antibodies against factor VIII.
    Leebeek FW; Kappers-Klunne MC; Jie KS
    Haemophilia; 2004 May; 10(3):250-3. PubMed ID: 15086322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NovoSeven for non-hemophilia hemostasis.
    Med Lett Drugs Ther; 2004 Apr; 46(1181):33-4. PubMed ID: 15114252
    [No Abstract]   [Full Text] [Related]  

  • 24. The concept of recombinant factor VIIa megadose for treating bleeding episodes in high-titer inhibitor patients with hemophilia: toward an expanding indication?
    Negrier C
    J Thromb Haemost; 2003 Mar; 1(3):423-4. PubMed ID: 12871444
    [No Abstract]   [Full Text] [Related]  

  • 25. Re: Discordant pair analysis of rFVIIa and pd-aPCC response.
    Cooper DL; Seremetis S; Carr ME
    Haemophilia; 2011 Mar; 17(2):323-5. PubMed ID: 21332885
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibitor challenges in the paediatric setting.
    Sieger L; Aledort L
    Haemophilia; 2006 Jan; 12(1):106-7. PubMed ID: 16409186
    [No Abstract]   [Full Text] [Related]  

  • 27. Recombinant FVIIa in the treatment of bleeding in acquired hemophilia.
    Guerin V; Chossat I; Dutronc H; Dubreuil M; Valentin F
    Am J Hematol; 2002 Aug; 70(4):333. PubMed ID: 12210820
    [No Abstract]   [Full Text] [Related]  

  • 28. Recombinant factor VIIa in paediatric bleeding disorders--a 2006 review.
    Mathew P; Young G
    Haemophilia; 2006 Sep; 12(5):457-72. PubMed ID: 16919075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Approaches to successful total knee arthroplasty in haemophilia A patients with inhibitors.
    Konkle BA; Nelson C; Forsyth A; Hume E
    Haemophilia; 2002 Sep; 8(5):706-10. PubMed ID: 12199684
    [No Abstract]   [Full Text] [Related]  

  • 30. Dose titration of recombinant factor VIIa using thromboelastograph monitoring in a child with hemophilia and high titer inhibitors to factor VIII: a case report and brief review.
    Trowbridge CC; Stammers AH; Ciccarelli N; Klayman M
    J Extra Corpor Technol; 2006 Sep; 38(3):254-9. PubMed ID: 17089513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor VIIa in European Haemophilia Centres.
    Morfini M; Auerswald G; Kobelt RA; Rivolta GF; Rodriguez-Martorell J; Scaraggi FA; Altisent C; Blatny J; Borel-Derlon A; Rossi V
    Haemophilia; 2007 Sep; 13(5):502-7. PubMed ID: 17880436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effective treatment with recombinant factor VIIa of severe bleeding due to acquired factor VIII inhibitor and acquired thrombocytopathy.
    Conesa V; Mompel A; Lopez F; Marín F; Ruiz J; Navarro F; Gomez A
    Am J Hematol; 2002 Aug; 70(4):329-30. PubMed ID: 12210816
    [No Abstract]   [Full Text] [Related]  

  • 33. Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with Haemophilia A and inhibitors.
    Hind D; Lloyd-Jones M; Makris M; Paisley S
    Cochrane Database Syst Rev; 2004; (2):CD004449. PubMed ID: 15106253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry.
    Parameswaran R; Shapiro AD; Gill JC; Kessler CM;
    Haemophilia; 2005 Mar; 11(2):100-6. PubMed ID: 15810910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential therapy with activated prothrombin complex concentrate and recombinant factor VIIa in patients with severe haemophilia and inhibitors.
    Schneiderman J; Nugent DJ; Young G
    Haemophilia; 2004 Jul; 10(4):347-51. PubMed ID: 15230948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful total hip replacement in a patient with severe haemophilia A with inhibitors using recombinant factor VIIa.
    Pasa S; Altintas A; Cil T; Danis R; Subasi M; Ayyildiz O; Muftuoglu E
    Haemophilia; 2008 Jul; 14(4):863-5. PubMed ID: 18445012
    [No Abstract]   [Full Text] [Related]  

  • 37. Successful management of Mallory-Weiss syndrome in a haemophilia A patient with inhibitor by recombinant activated factor VII.
    Uchida Y; Sakurai Y; Ogiwara K; Chiyonobu T; Higuchi B; Tanaka I; Shima M; Yoshioka A
    Haemophilia; 2008 Jul; 14(4):841-3. PubMed ID: 18445015
    [No Abstract]   [Full Text] [Related]  

  • 38. New approaches in the management of inhibitor patients.
    Young G
    Acta Haematol; 2006; 115(3-4):172-9. PubMed ID: 16549892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant factor VIIa: a review on its clinical use.
    Franchini M
    Int J Hematol; 2006 Feb; 83(2):126-38. PubMed ID: 16513530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful use of recombinant factor VIIa in pelvic fracture haemorrhage.
    Dhruva KK; Joel VD; Antony S; Vinodan K
    J Indian Med Assoc; 2006 Jan; 104(1):42, 44. PubMed ID: 16850866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.